Facebook Linkedin RSS Twitter Youtube
Home 2024

Regulatory policies

FDA Approves Lilly’s Amyloid-Targeting Kisunla for Early Alzheimer’s
Drug Discovery

FDA Approves Lilly’s Amyloid-Targeting Kisunla for Early Alzheimer’s

FDA Imposes Partial Hold on BioNTech/MedLink ADC Trial after Three Patient Deaths
Cancer

FDA Imposes Partial Hold on BioNTech/MedLink ADC Trial after Three Patient Deaths

New Research Power Ups Psilocybin’s Potential as an Antidepressant
News

New Research Power Ups Psilocybin’s Potential as an Antidepressant

Split Decision: Synthego Spins Out EditCo Bio Around Engineered Cell Platform
Bioprocessing

Split Decision: Synthego Spins Out EditCo Bio Around Engineered Cell Platform

StockWatch: CAR-T Shares Mostly Flat as FDA Probes Risk of New Cancers
Drug Discovery

StockWatch: CAR-T Shares Mostly Flat as FDA Probes Risk of New Cancers

Gene Therapy Briefs: Activist Investor Reported to Take $1B Stake in BioMarin
Drug Discovery

Gene Therapy Briefs: Activist Investor Reported to Take $1B Stake in BioMarin

Lonza Launches New Cell Line and MilliporeSigma Introduces Digital Reference Materials Platform
Bioprocessing

Lonza Launches New Cell Line and MilliporeSigma Introduces Digital Reference Materials Platform

Illumina Links Grail Divestiture to Losing European Or U.S. Appeals
Industry News

Illumina Links Grail Divestiture to Losing European Or U.S. Appeals

European Commission Orders Illumina to Divest of Grail
Industry News

European Commission Orders Illumina to Divest of Grail

Mixed-Mode Chromatography
Bioprocessing

Mixed-Mode Chromatography

123...6Page 1 of 6
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.